e-learning
resources
Glasgow 2004
Monday 06.09.2004
Descriptive epidemiology of sarcoidosis, tuberculosis and pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The development of pneumococcal infection in military populations
K. D. Jogolev, A. A. Kuzin, A. A. Kuzin (St Petersburg, Russia)
Source:
Annual Congress 2004 - Descriptive epidemiology of sarcoidosis, tuberculosis and pneumonia
Session:
Descriptive epidemiology of sarcoidosis, tuberculosis and pneumonia
Session type:
Thematic Poster Session
Number:
2275
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. D. Jogolev, A. A. Kuzin, A. A. Kuzin (St Petersburg, Russia). The development of pneumococcal infection in military populations. Eur Respir J 2004; 24: Suppl. 48, 2275
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Efficacy of vaccination to prevent pneumococcal infection in organized communities
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis
Year: 2017
The remaining challenges of pneumococcal disease in adults
Source: Eur Respir Rev 2012; 21: 57-65
Year: 2012
Serotype dynamics in pneumococcal diseases and the performance of vaccination strategies for older adults in germany
Source: Virtual Congress 2020 – How do different treatment strategies translate into costs
Year: 2020
Impact of pneumococcal vaccination in children in the distribution of serotypes in bacteriemic pneumococcal pneumonia in adults
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis
Year: 2017
Practicalities of human inoculation to establish experimental pneumococcal carriage in vaccine studies
Source: Annual Congress 2010 - Mechanisms of respiratory infections
Year: 2010
Dynamics of serotypic composition of nasopharyngeal pneumococcal isolates in children pneumococcal nasopharyngeal colonization after the introduction of the vaccination program in Moscow
Source: Virtual Congress 2020 – Different aspects of paediatric viral and bacterial lung infections
Year: 2020
Vaccination rates against pneumococcal and influenza infection in hospitalized cardiologic and pneumologic patients need to be improved.
Source: International Congress 2018 – Respiratory epidemiology: from infectious diseases to lung cancer
Year: 2018
Results of vaccination against pneumococcal infection in patients with chronic lung diseases
Source: International Congress 2019 – Airway infection in COPD
Year: 2019
Efficiency of specific prevention of pneumococcal infection at patients from risk groups in Krasnoyarsk region
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis
Year: 2017
Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects
Source: Eur Respir J 2005; 26: 1086-1091
Year: 2005
Influence of the infecting serotype on the development of complications in bacteriemic pneumococcal pneumonia with high inflammatory response
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
A nosocomial outbreak of influenza during a period without influenza epidemic activity
Source: Eur Respir J 2003; 21: 303-307
Year: 2003
The aetiology of community-acquired pneumonia among servicemen during armed conflict in the Northern Caucasus and the efficiency of pneumococcus vaccine for its prevention
Source: Eur Respir J 2001; 18: Suppl. 33, 463s
Year: 2001
Role of pneumococcal vaccine on the incidence of childhood empyema
Source: Breathe 2010; 6: 366-367
Year: 2010
Increased incidence of adult pneumococcal pneumonia during school holiday periods
Source: ERJ Open Res, 3 (1) 00100-2016; 10.1183/23120541.00100-2016
Year: 2017
Additive preventive effect of influenza and pneumococcal vaccines in elderly persons
Source: Eur Respir J 2004; 23: 363-368
Year: 2004
Societal perspective and challenges of influenza and pneumococcal vaccination in patients at risk of respiratory complications
Source: Annual Congress 2008 - Why vaccinate patients with chronic respiratory conditions? Today and tomorrow's perspectives
Year: 2008
Pneumococcal vaccination for preventing occupationally acquired infections in healthcare workers
Source: International Congress 2019 – Environment, work and respiratory health in occupational and environmental lung diseases
Year: 2019
Pneumococcal and influenza vaccination
Source: Respipedia Article
Year: 2018
Aetiology of paediatric pneumonia after the introduction of pneumococcal conjugate vaccine
Source: Eur Respir J 2013; 42: 1595-1603
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept